The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders

Psychoneuroendocrinology

Volumn 25, Issue 1, 2000, Pages 1-35

  Heim, Christine ^a   Ehlert, Ulrike ^a   Hellhammer, Dirk H ^a  

^a UNIVERSITY OF TRIER   (Germany)

Author keywords

Adrenal gland; Hypocortisolism; Stress related bodily disorders

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; DEXAMETHASONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; HYDROCORTISONE; METYRAPONE; TETRACOSACTIDE;

ADRENAL GLAND; ADRENAL INSUFFICIENCY; ANIMAL MODEL; ASTHMA; CHRONIC FATIGUE SYNDROME; COPING BEHAVIOR; DISEASE PREDISPOSITION; FEEDBACK SYSTEM; FIBROMYALGIA; GENETIC SUSCEPTIBILITY; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOCORTISOLISM; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; NEUROENDOCRINE SYSTEM; NONHUMAN; PATHOPHYSIOLOGY; PERSONALITY; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PSYCHOSOMATIC DISORDER; REGULATORY MECHANISM; REVIEW; RHEUMATOID ARTHRITIS; STRESS; THEORY;

ADAPTATION, PSYCHOLOGICAL; ADRENAL GLANDS; ANIMALS; CAUSALITY; CHRONIC DISEASE; CORTICOTROPIN-RELEASING HORMONE; DOWN-REGULATION; FEEDBACK; FEMALE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; PITUITARY-ADRENAL SYSTEM; PSYCHOPHYSIOLOGIC DISORDERS; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; RECEPTORS, GLUCOCORTICOID; SEX FACTORS; STRESS; STRESS DISORDERS, POST-TRAUMATIC;

EID: 0033992534     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4530(99)00035-9     Document Type: Review

References (210)

1. Ahles T.A., Yunus M.B., Riley S.D., Bradley J.M., Masi A.T. Psychological factors associated with primary fibromyalgia syndrome. Arthritis Rheum. 24:1984;1102-1106.
2. Alfvén G., de la Torre B., Uvnäs-Moberg K Depressed concentrations of oxytocin and cortisol in children with recurrent abdominal pain of non-organic origin. Acta Paediatr. 83:1994;1076-1080.
3. Allen K.N. Aspirin - now we can see it. Nat. Med. 1:1995;882-883.
4. Amir M., Kaplan Z., Neumann L., Sharabani R., Shani N., Buskila D. Posttraumatic Stess Disorder, tenderness, and fibromyalgia. J. Psychosom. Res. 42:1997;607-613.
5. Baker D., Mendenhall C.L., Simbratl L.A., Magan L.K., Steinberg J.L. Relationship between posttraumatic stress disorder and self-reported physical symptoms in Persian gulf war veterans. Arch. Intern. Med. 157:1982;2076-2078.
6. Bateman A., Singh A., Kral T., Solomon S. The immune hypothalamic pituitary adrenal axis. Endocr. Rev. 10:1989;92-112.
7. Baum A., Cohen L., Hall M. Control and intrusive memories as possible determinants of chronic stress. Psychosom. Med. 55:1993;274-286.
8. Bearn J., Allain T., Coskeran P., Munro N., Butler J., McGregor A., Wessely S. Neuroendocrine responses to d-fenfluramine and insulin-onduced hypoglycemia in chronic fatigue syndrome. Biol. Psychiatry. 37:1995;245-252.
9. Benedetto C. Eicosanoids in primary dysmenorrhea, endometriosis and menstrual migraine. Gynecol. Endocrinol. 3:1989;71-94.
10. Blackwell G.J., Carnuccio R., DiRosa M. et al. Glucocorticoids induce the formation and release of anti-inflammatory and anti-phospholipase proteins into the peritoneal cavity of the rat. Br. J. Pharmacol. 76:1982;185-194.
11. Boisset-Pioro M.H., Esdaile J.M., Fitzcharles M.A. Sexual and physical abuse in women with fibromyalgia syndrome. Arthritis Rheum. 38:1995;235-241.
12. Boscarino J.A. Posttraumatic stress disorder, exposure to combat, and lower plasma cortisol among Vietnam veterans: Findings and clinical implications. J. Clin. Consult. Psychol. 64:1996;191-201.
13. Bourne P.G., Rose R.M., Mason J.W. 17 OHCS levels in combat. Special forces 'A' team under threat of attack. Arch. Gen. Psychiatry. 19:1968;135-140.
14. Bourne P.G., Rose R.M., Mason J.W. Urinary 17 OHCS levels. Data on seven helicopter ambulance medics in combat. Arch. Gen. Psychiatry. 17:1967;104-110.
15. Boxer G.H., Carson J., Miller B.D. Neglect contributing to tertiary hospitalization in childhood asthma. Child Abuse Negl. 12:1988;491-501.
16. Bremner J.D., Randall P., Scott T.M. et al. MRI-based measurement of hippocampal volume in patients with combat-related posttraumatic stress disorder. Am. J. Psychiatry. 152:1995;973-981.
17. Bremner J.D., Licino J., Darnell A. et al. Elevated CSF corticotropin-releasing factor concentrations in PTSD. Am. J. Psychiatry. 154:1997;624-629.
18. Bremner J.D., Randall P., Vermetten E. et al. Magnetic resonance imaging-based measurement of hippocampal volume in posttraumatic stress disorder related to childhood physical and sexual abuse - a preliminary report. Biol. Psychiatry. 41:1998;23-32.
19. Bremner J.D., Southwick S.M., Johnson D.R., Yehuda R., Charney D.S. Childhood physical abuse and combat-related posttraumatic stress disorder in Vietnam veterans. Am. J. Psychiatry. 150:1993;235-239.
20. Buchwald D., Komaroff A.L. Review of laboratory findings for patients with chronic fatigue syndrome. Rev. Infect. Dis. 13:1991;12-18.
21. Buske-Kirschbaum A., Jobst S., Wustmans A., Kirschbaum C., Rauh W., Hellhammer D.H. Attenuated free cortisol response to psychosocial stress in children with atopic dermatitis. Psychosom. Med. 59:1997;419-426.
22. Caplan R.D., Cobb S., French J.R. White collar work load and cortisol: disruption of a circadian rhythm by job stress? J. Psychosom. Res. 23:1979;181-192.
23. Cash J.M., Crofford L.J., Galucci W.T. et al. Pituitary-adrenal axis responsiveness to ovine corticotropin releasing hormone in patients with rheumatoid arthritis treated with low dose prednisone. J. Rheumatol. 19:1992;1692-1696.
24. Catalani A., Marinelli M., Scaccianoce S. et al. Progeny of mothers drinking corticosterone during lactation has lower stress-induced corticosterone secretion and better cognitive performance. Brain Res. 624:1993;209-215.
25. Cavallo R., Sartori M.L., Gatti G., Angeli A. Cortisol and immune interferon can interact in the modulation of human natural killer cell activity. Experimentia. 42:1986;177.
26. Chikanza I.C., Petrou P., Chrousos G.P., Kingsley G., Panayi G.P. Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis. Arthritis Rheum. 35:1992;1281-1288.
27. Clark S., Tindell E., Bennett R.M. A double blind crossover trial of prednisone versus placebo in the treatment of fibrositis. J. Rheumatol. 12:1985;980-983.
28. Cleare A.J., Heap E., Wessely S., O'Keane V., Miell J. Low dose hydrocortisone in chronic fatigue syndrome: a randomized crossover trial. Lancet. 353:1999;455-458.
29. Coplan J.D., Andrews M.W., Rosenblum L.A. et al. Persistent elevations of cerebrospinal fluid concentrations of corticotropin-releasing factor in adult nonhuman primates exposed to early life stressors: Implications for the pathophysiology of mood and anxiety disorders. Proc. Natl. Acad. Sci. USA. 93:1996;1619-1623.
30. Corrigan C.J., Brown P.H., Barnes N.C. et al. Glucocorticoid resistance in chronic asthma. Glucocorticoid pharmacokinetics, glucocorticoid receptor characteristics, and inhibition of peripheral blood T cell proliferation by glucocorticoids in vitro. Am. Rev. Respir. Dis. 144:1991;1016-1025.
31. Cox B.J., Kuch K., Parker J.D.A., Shulman I.D., Evans R.J. Alexithymia in somatoform disorder patients with chronic pain. J. Psychosom. Res. 38:1994;523-527.
32. Crofford L.J., Pillemer S.R., Kalogeras K.T. et al. Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia. Arthritis Rheum. 37:1994;1583-1592.
33. Culclasure T.F., Enzenauer R.J., West S.G. Posttraumatic stress disorder presenting as fibromyalgia. Am. J. Med. 94:1993;548.
34. Davidson J., Swartz M., Storck M., Krishnan R.R., Hammett E. A diagnostic and family study of posttraumatic stress disorder. Am. J. Psychiatry. 142:1985;90-93.
35. Davidson J.R.T., Hughes D., Blazer D.G., George L.K. Posttraumatic stress disorder in the community: an epidemiological study. Psychol. Med. 21:1991;713-721.
36. DeBellis M.D., Chrousos G.P., Dorn L.D. et al. Hypothalamic pituitary adrenal axis dysregulation in sexually abused girls. J. Clin. Endocrinol. Metab. 78:1994;249-255.
37. DeBellis M.D. Antinuclaer autoantibodies and thyroid function in sexually abused girls. J. Trauma. Stress. 9:1996;369-378.
38. De Castro M., Elliot S., Kino T. et al. The non-ligand binding b-isoform of the human glucocorticoid receptor (hGRb): Tissue levels, mechanism of action, and potential physiological role. Mol. Med. 2:1996;597-607.
39. DeGoeij D.C., Jezova D., Tilders F.J. Repaeted stress enhances vasopression synthesis in corticotropin releasing factor neurons in the paraventricular nucleus. Brain Res. 577:1992;165-168.
40. Dekaris D., Sabioncello A., Mazuran R. et al. Multiple changes of immunologic parameters in prisoners of war. J. Am. Med. Assoc. 270:1993;595-599.
41. deKloet E.R. Brain corticosteroid receptor balance and homeostatic control. Front. Neuroendocrinol. 12:1991;95-164.
42. Delahanty D.L., Dougall A.L., Craig K.J., Jemkins F.J., Baum A. Chronic stress and natural killer cell activity after exposure to traumatic death. Psychosom. Med. 59:1997;467-476.
43. Demitrack M.A., Dale J.K., Straus S.E. et al. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J. Clin. Endocrinol. Metab. 73:1991;1224-1234.
44. Dhabhar F.S., McEwen B.S., Spencer R.L. Stress response, adrenal steroid receptor levels and corticosteroid binding globulin levels - a comparison between Sprague-Dawley, Fischer 344 and Lewis rats. Brain Res. 616:1993;89-98.
45. Dhabhar F.S., McEwen B.S. Stress-induced enhancement of antigen-specific cell-mediated immunity. J. Immunol. 156:1996;2608-2615.
46. Dhabhar F.S., McEwen B.S. Acute stress enhances while chronic stress suppresses immune function in vivo: a potential role for leukocyte trafficking. Brain, Behav. Immun. 11:1997;286-306.
47. Dhabhar F.S., McEwen B.S. Enhancing versus suppressive effects of stress hormones on skin immune function. Proc. Natl. Acad. Sci. USA. 96:1999;1059-1064.
48. Dienstbier R.A. Arousal and physiological toughness: implications for mental and physical health. Psycholog. Rev. 96:1989;84-100.
49. Dupont E., Huygen K., Schandene L., Vandercruys M., Palfliet K., Wybran J. Influence of in vivo immunosuppressive drugs on production of lymphokines. Transplantation. 39:1985;143.
50. Dutton L.M., Smolensky M.H., Leach C.S., Lorimor R., Hsi B.P. Stress levels of ambulance paramedics and fire fighters. J. Occup. Med. 20:1978;111-115.
51. Ehlert U., Locher P., Hanker J.P. Psychoendokrinologische Untersuchungen bei Frauen mit chronischen Unterbauchbeschwerden. Kentenich H. Psychosomatische Gynaekologie und Geburtshilfe. 1993;Springer, Berlin.
52. Elwan O., Abdella M., El Bayad A.B., Hamdy S. Hormonal changes in headache patients. J. Neurol. Sci. 106:1991;75-81.
53. Faessler R., Schauenstein K., Kroemer G., Schwarz S., Wick G. Elevation of corticosteroid binding globulin in obese strain (OS) chickens: possible implications for the disturbed immunoregulation and the dvelopment of spontaneous autoimmune thyroiditis. J. Immunol. 136:1986;3657-3661.
54. Fameli M., Kitraki E., Stylianopoulou F. Effects of hyperactivity of the maternal hypothalamic-pituitary-adrenal (HPA) axis during pregnancy on the development of the HPA axis and brain monoamiines in the offspring. Int. J. Dev. Neurosci. 12:1994;651-659.
55. Fauci A.S. Mechanism of corticosteroid action on lymphocyte subpopulations. I. Redistribution of circulating T and B lymphocytes to the bone marrow. Immunology. 28:1975;669.
56. Fauci A.S. Mechanism of corticosteroid action on lymphocyte subpopulations. II. Differential effects of in vivo hydrocortisone, prednisone and dexamethasone on in vitro expression of lymphocyte function. Clin. Exp. Immunol. 24:1976;54.
57. Fehm-Wolfsdorf G. Stress und Wahrnehmung. Psychobiologie der Glucocorticoide. 1994;Hans Huber, Bern.
58. Ferraccioli G., Cavalieri F., Salaffi F. et al. Neuroendocrinologic findings in primary fibromylagia and in other chronic rheumatic conditions. J. Rheumatol. 17:1990;869-873.
59. 2 inhibitor which prevents prostaglandin generation. Nature. 278:1979;456-459.
60. Foy D.W., Resnick H.S., Sipprelle R.C., Carroll E.M. Premilitary, military, and postmilitary factors in the development of combat-related stress disorders. Behav. Ther. 10:1987;3-9.
61. France R.D., Krishnan K.R. The dexamethasone suppression test as a biologic marker of depression in chronic pain. Pain. 21:1985;49-55.
62. Friedman S.B., Mason J.W., Hanburg D.A. Urinary 17-hydroxycorticosteroid levels in parents of children with neoplastic disease: a study of chronic psychological stress. Psychosom. Med. 25:1963;364-376.
63. Gatti G., Cavallo R., Sartori M.L. et al. Inhibition by cortisol of human natural killer (NK) cell activity. J. Steroid Biochem. 26:1987;49-58.
64. Genazzani A.R., Lemarchand-Beraud T.H., Aubert M.L., Felber J.P. Pattern of plasma ACTH, hGH, and cortisol during menstrual cycle. J. Clin. Endocrinol. Metab. 41:1975;431-437.
65. Gerhards T., Yehuda R., Shoham M., Hellhammer D.H. Abnormal cerebral laterality in posttraumatic stress disorder. Ann. NY Acad. Sci. 821:1997;482-485.
66. Goenjian A.K., Yehuda R., Pynoos R.S. et al. Basal cortisol and dexamethasone suppression oc cortisol among adolescents after the 1988 earthquake in Armenia. Am. J. Psychiatry. 153:1996;929-934.
67. Gómez F., Lahmame A., de Kloet E.R., Armario A. Hypothalamic-pituitary-adrenal response to chronic stress in five inbred rat strains: differential responses are mainly located on the adrenocortical level. Neuroendocrinology. 63:1996;327-337.
68. Green M.A., Berlin M.A. Five psychosocial variables related to the existence of posttraumatic stress disorder symptoms. J. Clin. Psychol. 43:1987;643-649.
69. Griep E.N., Boersma J.W., deKloet E.R. Altered reactivity of the hypothalamic-pituitary-adrenal axis in the primary fibromyalgia syndrome. J. Rheumatol. 20:1993;469-474.
70. Griep E.N., Boersma J.W., Lentjes E.G., Prins P.A., van der Korst K.K., deKloet E.R. Function of hypothalamic-pituitary-adrenal axis in patients with fibromyalgia and low back pain. J. Rheumatol. 25:1998;1374-1381.
71. Gurvits T.G., Shenton M.R., Hokama H. et al. Magnetic resonance imaging study of hippocampal volume in chronic, combat-related psottraumatic stress disorder. Biol. Psychiatry. 40:1996;193-199.
72. Haas D.A., George S.R. Single or repeated mild stress increases synthesis and release of hypothalamic corticotropin-releasing factor. Brain Res. 461:1988;230-237.
73. Hamaty D., Valentine J.L., Howard C.W., Wakefield V., Patten M.S. The plasma endorphin, prostaglandin and catecholamine profile of patients with fibrositis treated with cyclobenzaprine and placebo: a 5 month study. J. Rheumatol. 19:1989;164-168.
74. Handwerker H.O. Influences of algogenic substances and prostaglandins on the discharges of unmyelinated cutaneous nerve fibers identified as nociceptors. Bonica J.J., Albe-Fessard D. Advances in Pain Research and Therapy. 1976;Raven Press, New York.
75. Hauger R.L., Lorang M., Irwin M., Aguilera G. CRF receptor regulation and sensitization of ACTH responses to acute ether stress during chronic intermittent immobilization stress. Endocrinology. 123:1990;396-405.
76. Hauger R.L., Millan M.A., Lorang M., Harwood J.P., Aguilera G. Corticotropin-releasing factor receptors and pituitary adrenal responses during immobilization stress. Endocrinology. 123:1988;396-405.
77. Hedman M., Nilsson E., de la Torre B. Low blood and synovial fluid levels of sulpho-conjugated steroids in rheumatoid arthritis. Clin. Exp. Rheumatol. 10:1992;25-30.
78. Heim C., Ehlert U., Rexhausen J., Hanker J.P., Hellhammer D.H. Psychoendocrinological observations in women with chronic pelvic pain. Ann. NY Acad. Sci. 821:1997;456-458.
79. Heim C., Owens M.J., Plotsky P.M., Nemeroff C.B. The role of early adverse life events in the etiology of major depression and posttraumatic stress disorder: focus on corticotropin-releasing factor. Ann. NY Acad. Sci. 821:1997;194-207.
80. Heim C., Ehlert U., Hanker J.P., Hellhammer D.H. Abuse-related posttraumatic stress disorder and alterations of the hypothalamic-pituitary-adrenal axis in women with chronic pelvic pain. Psychosom. Med. 60:1998;309-318.
81. Heim C., Pisell T.L., Pearce B.D., Miller A.H. Discrimination of activation versus down-regulaion of the glucocortical receptor using a cytosolic binding assay combined with a whole cell Western blot. Soc. Neurosci. Abstr. 27:1998b;4901.
82. Heim, C., Ehlert, U., Hanker, J.P., Hellhammer, D.H., 1999. Psychological and endocrine correlates of chronic pelvic pain associated with adhesions. J. Psychosom. Obstet. Gynecol. 20, 11-20.
83. Hellhammer, J., 1990. Burnout bei Pflegepersonal - eine psychoendokrinologische Untersuchung. Diploma Thesis, University of Trier, Germany.
84. Hellhammer D.H., Wade S. Endocrine correlates of stress vulnerability. Psychother. Psychosom. 60:1993;8-17.
85. Henry J.P. Psychological and physiological responses to stress: the right hemisphere and the hypothalamo-pituitary-adrenal axis. An inquiry into problems of human bonding. Integr. Physiol. Behav. Sci. 28:1993;368-387.
86. Henry J.P., Haviland M.G., Cummings M.A. et al. Shared neuroendocrine patterns of post-traumatic stress disorder and alexithymia. Psychosom. Med. 54:1992;407-415.
87. Hingtgen C.M., Vasko M.R. Prostacyclin enhances the evoked release of substance P and calcitonin gene related peptide from rat sensory neurons. Brain Res. 655:1994;51-60.
88. Hirschberg H., Hirschberg T., Nousiainen H., Braathen L.R., Jaffe E. The effects of corticosteroids on the antigen presenting properties of human monocytes and endothelial cells. Clin. Immunol. Immunopathol. 23:1982;577.
89. Holsboer F., Gerken A., Stalla G.K., Mueller O.A. ACTH, cortisol and corticosterone output after ovine corticotropin-releasing factor challenge during depression and after recovery. Biol. Psychiatry. 20:1985;276-286.
90. Hudson J.I., Pope H.G. The concept of affective spectrum disorder: releationship of fibromyalgia and other syndromes of chronic fatigue and chronic muscle pain. Bailliere's Clin. Rheumatol. 4:1994;839-856.
91. Hudson J.I., Pliner L.F., Hudson M.S., Goldenberg D.L., Melby J.C. The dexamethasone suppression test in fibrositis. Biol. Psychiatry. 19:1984;1489-1493.
92. Hug C., Gerber N.J. Fibromyalgiesyndrom oft verkannte Realitaet. Schweiz. Med. Wochenschr. 120:1990;395-401.
93. Imaki T., Nahan J.L., Rivier C., Sawchenko P.E., Vale W. Differential regulation of corticotropin-releasing factor mRNA in rat brain regions by glucocorticoids and stress. J. Neurosci. 11:1991;585-599.
94. Iowa Persian Gulf Study Group, 1997. Self reported illness and health status among Gulf War veterans. A population-based study. J. Am. Med. Assoc. 277, 238-245.
95. Johansson F. Differences in serum cortisol concentrations in organic and psychogenic chronic pain syndromes. J. Psychosom. Res. 26:1981;351-358.
96. Kam J.C., Szefler S.J., Surs W., Sher E.R., Leung D.Y.M. Combination of IL-2 and IL-4 reduces glucocorticoid receptor-binding affinity and T cell response to glucocorticoids. J. Immunol. 151:1993;3460-3466.
97. Kaplan N.M. The adrenal glands. Griffin J.E., Ojeda S.R. Textbook of Endocrine Physiology. 1988;Oxford University Press, New York.
98. Katz J.L., Weiner H., Gallagher T.F., Hellman L. Stress, distress, and ego defenses. Psychoendocrine response to impending breast tumor biopsy. Arch. Gen. Psychiatry. 23:1970;131-142.
99. Kaufman J., Birmaher B., Perel J. et al. The corticotropin-releasing hormone challenge in depressed abused, depressed nonabused, and normal control children. Biol. Psychiatry. 42:1997;669-679.
100. Kelso A., Munck A. Glucocorticoid inhibition of lymphokine secretion by alloreactive T-lymphocyte clones. J. Immunol. 133:1984;784-791.
101. Kirschbaum C., Wüst S., Faig H.G., Hellhammer D.H. Heritability of cortisol responses to hCRH, ergometry, and psychological stress in humans. J. Clin. Endocrinol. Metab. 75:1992;1526-1530.
102. Kruger U., Spiecker H. Die Diagnostik der Nebennierenrindeninsuffizienz bei steroidpflichtigem Asthma bronchiale: Der CRH-Test im Vergleich zu Kortisol Tagesprofil im Serum und Kortisol im 24h-Urin. Pneumologie. 48:1994;789-793.
103. Ladd C.O., Owens M.J., Nemeroff C.B. Persistent changes in corticotropin-releasing factor neuronal systems induced by maternal deprivation. Endocrinology. 137:1996;1212-1218.
104. Lentjes E.G., Griep E.N., Boersma J.W., Romijn F.P., de Kloet E.R. Glucocorticoid receptors, fibromyalgia and low back pain. Psychoneuroendocrinology. 22:1998;603-614.
105. Lykken D.T., Iacono K.H., Haroian K. Habituation of the skin conductance in response to strong stimuli: a twin study. Psychophysiology. 25:1988;4-15.
106. Makino S., Gold P.W., Schulkin J. Corticosterone effects on corticotropin-releasing hormone mRNA in the central nucleus of the amygdala and the parvocellular region of the paraventricular nucleus of the hypothalamus. Brain Res. 640:1994;105-112.
107. Mason J.W., Brady J.V., Tolliver G.A. Plasma and urinary 17-hydroxycorticosteroid responses to 72-hr. avoidance sessions in the monkey. Psychosom. Med. 30:1968;608-630.
108. Mason J.W., Giller E.L., Kosten T.R., Harkness L. Elevation of urinary norepinephrine/cortisol ratio in posttraumatic stress disorder. J. Nerv. Ment. Dis. 176:1988;498-502.
109. Mason J.W., Giller E.L., Kosten T.R., Ostroff R.B., Podd L. Urinary free-cortisol levels in post-traumatic stress disorder patients. J. Nerv. Ment. Dis. 174:1986;145-159.
110. McCain G.A., Tilbe K.S. Diurnal hormone variation in fibromyalgia syndrome: a comparison with rheumatoid arthritis. J. Rheumatol. 16:1989;154-157.
111. McCranie E.W., Hyer L.A., Boudewyns P.A., Woods M.G. Negative parenting behavior. Combat exposure, and PTSD sympton severity: test of a person-event interaction model. J. Nervous Mental Dis. 180:1992;431-438.
112. McEwen B.S., Biron C.A., Brunson K.W. et al. The role of adrenocorticoids as modulators of immune function in health and disease: neural, endocrine and immune interactions. Brain Res. Rev. 23:1997;79-133.
113. McEwen B.S. Protective and damaging effects of stress mediators. N. Engl. J. Med. 338:1998;171-179.
114. McEwen B.S. Stress and the aging hippocampus. Front. Neuroendocrinol. 20:1999;1-22.
115. McFarlane A.C. Posttraumatic morbidity of a disaster: a study of cases presenting for psychiatric treatment. J. Nerv. Ment. Dis. 174:1988;4-14.
116. McKenzie R., O'Fallon A., Dale J. et al. Low-dose hydrocortisone for treatment of chronic fatigue syndrome. J. Am. Med. Assoc. 280:1998;1061-1066.
117. Meaney M.J., Tannebaum P., Francis D. et al. Early environmental programming of hypothalamic-pituitary-adrenal responses to stress. Semin. Neurosci. 6:1994;247-259.
118. Meikle A.W., Bishop D.T., Stringham J.D., Ford M.H., West D.W. Relationship between body mass index, cigarette smoking and plasma sex steroids in normal male twins. Genetic Epidemiol. 6:1989;399-412.
119. Monjan A.A., Collector M.I. Stress-induced modulation of of the immune response. Science. 196:1977;307-308.
120. Morand E.F., Jefferiss C.M., Dixey J., Mitra D., Goulding N.J. Impaired glucocorticoid induction of mononuclear leukocyte lipocortin-1 in rheumatoid arthritis. Arthritis Rheum. 37:1994;207-211.
121. Munck A., Guyre P.M., Holbrook N.J. Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocr. Rev. 5:1984;25-44.
122. Murison R., Overmier J.B., Skoglund E.J. Serial stressors: prior exposure to a stressor modulates its later effectiveness on gastric ulceration and corticosterone release. Behav. Neural Biol. 45:1986;185-195.
123. Natelson B.H., Ottenweller J.E., Cook J.A., Pitman D., McCarthy R., Tapp W.N. Effect of stressor intensity on habituation of the adrenocortical stress response. Physiol. Behav. 43:1988;41-46.
124. Neeck G., Federlin K, . Graef V., Rusch D., Schmidt K.L. Adrenal secretion of cortisol in patients with rheumatoid arthritis. J. Rheumatol. 17:1990;24-29.
125. Neeck G., Federlin K, . Graef V., Rusch D., Schmidt K.L. Adrenal secretion of cortisol in patients with rheumatoid arthritis. J. Rheumatol. 17:1992;24-29.
126. Nemeroff C.B. The corticotropin-releasing factor (CRF) hypothesis of depression: new findings and new directions. Mol. Psychiatry. 1:1996;336-342.
127. Nemeroff C.B., Krishnan K.R., Reed D., Leder R., Beam C., Dunnick N.R. Adrenal gland enlargement in major depression. Arch. Gen. Psychiatry. 49:1993;384-387.
128. 2 increases calcium conductance and stimulates release of substance P in avian sensory neurons. J. Neurosci. 12:1992;1917-1927.
129. Nimmagadda S.R., Szefler S.J., Spahn J.D., Surs W., Leung D.Y.M. Allergen exposure decreases glucocorticoid receptor binding affinity and steroid responsiveness in atopic asthmatics. Am. J. Resp. Crit. Care Med. 155:1997;87-93.
130. Nyklíček M.A., Vingerhoets A.J. Alexithymia is associated with low tolerance to experimental painful stimulation. Psychosom. Med. 58:1996;66.
131. Oakley R.H., Sar M., Cidlowski J.A. The human glucocorticoid receptor b isoform. Expression, biochemical properties, and putative function. J. Biol. Chem. 271:1996;9550-9559.
132. Orr T.E., Meyerhoff J.L., Mougey E.H., Bunnell B.N. Hyperresponsiveness of the rat neuroendocrine system due to repeated exposure to stress. Psychoneuroendocrinology. 15:1990;317-328.
133. Orth D.N., Kovacs W.J., deBold C.R. The adrenal cortex. Wilson J.D., Foster D.W. Williams Textbook of Endocrinology. 1992;489-619 Saunders, Philadelphia.
134. Ottenweller J.E., Natelson B.H., Pitman D.L., Drastal S.D. Adrenocortical and behavioral responses to repeated stressors: toward an animal model of chronic stress and stress-related mental illness. Biol. Psychiatry. 26:1989;829-841.
135. Owens M.J., Nemeroff C.B. Physiology and pharmacology of corticotropin-releasing factor. Pharm. Rev. 43:1991;425-473.
136. Pavcovich L.A., Valentino R.J. Regulation of a putative neurotransmitter effect of corticotropin-releasing factor: effects of adrenalectomy. J. Neurosci. 17:1997;401-408.
137. Pariante C.M., Pearce B.D., Pisell T.L., Owens M.J., Miller A.H. Steroid-independent translocation of the glucocorticoid receptor by the antidepresant desipramine. Mol. Pharmacol. 52:1997;571-581.
138. Pariante C.M., Pearce B.D., Pisell T.L. et al. The proinflammatory cytokine, interleukin-1 alpha, reduces glucocorticoid receptor translocation and function. Soc. Neurosci. Abstr. 24:1997;201.1.
139. Piazza P.V., LeMoal M. Glucocorticoids as a biological substrate for reward: Physiological and pathophysiological implications. Brain Res. Rev. 25:1997;359-372.
140. Poteliakhoff A. Adrenocortical activity and some clinical findings in acute and chronic fatigue. J. Psychosom. Res. 25:1981;91-95.
141. Pruessner J., Hellhammer D.H., Kirschbaum C. Burnout, perceived stress and salivary cortisol upon awakening. Psychosom. Med. 61:1999;197-294.
142. Rivier C., Vale W. Diminished responsiveness of the hypothalamic pituitary adrenal axis of the rat during exposure to prolonged stress: a pituitary mediated-mechanism. Endocrinology. 121:1987;1320-1328.
143. Rose R.M., Poe R.O., Mason J.W. Psychological state and body size as determinants of 17-OHLS excretion. Arch. Intern. Med. 121:1968;406-413.
144. Rosmond R., Dallman M.F., Bjorntorp P. Stress-related cortisol secretion in men: Relationships between abdominal obesity and endocrine, metabolic and hemodynamic abnormalities. J. Clin. Endocrinol. Metab. 83:1998;1853-1859.
145. Rubin R.T., Phillips J.J., Sadow T.F., McCracken J.T. Adrenal gland volume in major depression: increase during depressive episode and decrease with successful treatment. Arch. Gen. Psychiatry. 52:1995;213-218.
146. Ruch L.O., Chandler S.M., Harter R.A. Life change and rape impact. J. Health Soc. Behav. 21:1980;248-260.
147. Rupprecht M., Rupprecht R., Kornhuber J. et al. Elevated glucocorticoid receptor concentrations before and after glucocorticoid therapy in peripheral mononuclear leukocytes of patients with atopic dermatitis. Dermatologica. 183:1991;100-105.
148. Sapolsky R.M., Krey L.C., McEwen B.S. Prolonged glucocorticoid exposure reduces hippocampal neuron number: implications for aging. J. Neurosci. 5:1985;1222-1227.
149. Sapolsky R.M., Krey L.C., McEwen B.S. The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. Endoc. Rev. 7:1986;284-301.
150. Schaffner A. Therapeutic concentrations of glucocorticoids suppress the antimicrobial activity of human macrophages without impairing their responsiveness to interferon. J. Clin. Investig. 76:1985;1755.
151. Schlaghecke R., Kornely E., Wollenhaupt J., Specker C. Glucocorticoid receptors in rheumatoid arthritis. Arthritis Rheum. 35:1992;740-744.
152. Schmid-Ott G., Jacobs R., Jager B. et al. Stress-induced endocrine and immunological changes in psoriasis patients and healthy controls. Psychother. Psychosom. 67:1998;37-42.
153. Scott M.J., Stradling S.G. Post traumatic stress disorder without the trauma. Br. J. Clin. Psychol. 33:1994;71-74.
154. Scott L.V., Medbak S., Dinan T.G. Blunted adrenocorticotropin and cortisol responses to corticotropin-releasing hormone stimulation in chronic fatigue syndrome. Acta Psychiatr. Scand. 97:1998;450-457.
155. Scott L.V., Medbak S., Dinan T.G. The low dose ACTH test in chronic fatigue syndrome and in health. Clin. Endocrinol. 48:1998;733-737.
156. Seligman M.E.P. Helplessness. 1975;Freeman, San Francisco.
157. Selye H. A syndrome produced by diverse noxious agents. Nature. 138:1936;32-36.
158. Sephton S.E., Sapolski R.M., Kraemer H.C., Spiegel D. Absence of diurnal cortisol variation predicts early breast cancer mortality. Psychoneuroendocrinology. 23:1998;S51.
159. Sharav Y., Singer E., Schmidt E., Dionne R.A., Dubner R. The analgesic effect of amitriptyline on chronic facial pain. Pain. 31:1987;199-209.
160. Sher E.R., Leung Y.M., Surs W. Steroid-resistant asthma. Cellular mechanisms contributing to inadequate response to glucocorticoid therapy. J. Clin. Investig. 93:1994;33-39.
161. Sieber W.J., Holbrook T., Browner D. Predictors of PTSD in a physically traumatized population. Psychosom. Med. 58:1996;95.
162. Smith M.A., Davidson J., Ritchie J.C., Kudler H., Lipper S., Chappell P., Nemeroff C.B. The corticotropin-releasing hormone test in patients with posttraumatic stress disorder. Biol. Psychiatry. 26:1989;349-355.
163. Smyth J., Ockenfels M.C., Porter L., Kirschbaum C., Hellhammer D.H., Stone A. Stressors and mood measured on a momentary basis are associated with salivary cortisol secretion. Psychoneuroendocrinology. 23:1998;353-370.
164. Spahn J.D., Leung D.Y.M., Surs W., Harbeck R.J., Nimmagadda S., Szefler S.J. Reduced glucocorticoid binding affinity in asthma is related to ongoing allergic inflammation. Am. J. Resp. Crit. Care Med. 151:1995;1709-1714.
165. Spahn J.D., Szefler S.J., Surs W., Doherty D.E., Nimmagadda S., Leung D.Y.M. A novel action of IL-13. Induction of diminished monocyte glucocorticoid receptor-binding affinity. J. Immunol. 157:1996;2654-2659.
166. Spivak B., Shohat B., Mester R. et al. Elevated levels of serum interleukin-1β in combat-related posttraumatic stress disorder. Biol. Psychiatry. 42:1997;345-348.
167. Stein M.B., Yehuda R., Koverola C., Hanna C. Enhanced dexamethasone suppression of plasma cortisol in a adult women traumatized by childhood sexual abuse. Biol. Psychiatry. 42:1997;680-686.
168. Stein M.B., Koverola C., Hanna C., Torchia M.G., McClarty B. Hippocampal volume in women victimized by childhood sexual abuse. Psychol. Med. 27:1997;951-959.
169. Sternberg E.M., Hill J.M., Chrousos G.P. et al. Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis-rats. Proc. Natl. Acad. Sci. USA. 86:1989;2374-2378.
170. Sternberg E.M., Young W.S., Bernardini R. et al. A central nervous system defect in biosynthesis of corticotropin releasing hormone is associated with susceptibility to streptococcal cell wall induced arthritis in Lewis rats. Proc. Natl. Acad. Sci. USA. 86:1989;4771-4775.
171. Sternberg E.M. Hypoimmune fatigue syndromes: diseases of the stress response? J. Rheumatol. 20:1993;418-421.
172. Stokes P.E., Stoll P.M., Koslow S.H. et al. Pretreatment DST and hypothalamic pituitary adrenocortical function in depressed patients and comparison groups. A multicenter study. Arch. Gen. Psychiatry. 41:1984;257-267.
173. Stone A.A., Schwartz J.E., Neale J.M. et al. How accurate are current coping assessments? A comparison of momentary versus end-of-day reports of coping efforts. J. Personal. Soc. Psychol. 74:1998;1670-1680.
174. Stratakis C.A., Karl M., Schulte H.M., Chrousos G.P. Glucocorticosteroid resistance in humans. Elucidation of the molecular mechanisms and implications for pathophysiology. Ann. NY Acad. Sci. 746:1994;362-376.
175. Swanson L.W., Simmons O.M. Differential steroid hormone and neural influences on peptide mRNA levels in CRH cells of the paraventricular nucleus: a hybridization histochemical study in the rat. J. Comp. Neural. 285:1989;413-435.
176. Takasu N., Komiya I., Nagasawa Y., Asawa T., Yamada T. Exacerbation of autoimmune thyroid dysfunction after unilateral adrenalectomy in patients with Cushing's syndrome due to an adrenocortical adenoma. N. Engl. J. Med. 322:1990;1708-1712.
177. Tandon R., Haskett R.F., Cardona D., Alcser K., Greden J.F. Menstrual cycle effects on the dexamethasone suppression test in major depression. Biol. Psychiatry. 47:1991;512-527.
178. Taylor G.J., Ryan D.P., Bagby R.M. Toward the development of a new self-report alexithymia-scale. Psychother. Psychosom. 44:1985;191-199.
179. Tersman Z., Collins A., Eneroth P. Cardiovascular responses to psychological and physiological stressors during the menstrual cycle. Psychosom. Med. 53:1991;185-197.
180. Thompson S.P., McMahon L.J., Nugent C.C. Endogenous cortisol: a regulator of the number of lymphocytes in peripheral blood. Clin. Immunol. Immunopathol. 17:1980;506-514.
181. True W.R., Rice J., Eisen S.A. et al. A twin study of genetic and environmental contributions to liability for posttraumatic stress symptoms. Arch. Gen. Psychiatry. 50:1993;257-264.
182. Valdés M., Garcia L., Treserra J., de Pablo J, de Flores T. Psychogenic pain and depressive disorders: a empirical study. J. Affect. Disord. 16:1989;21-25.
183. van Denderen J.C., Boersma J.W., Zeinstra P., Hollander A.P., van Neerbos B.R. Physiological effects of exhaustive physical exercise in primary fibromyalgia syndrome (PFS). Scand. J. Rheumatol. 21:1992;35-37.
184. Verheggen M.M., van Hal P.T., Adriaansen-Soeting P.W.C. et al. Modulation of glucocorticoid receptor expression in human bronchial epithelial cell lines by IL-1β, TNF-α and LPS. Eur. Resp. J. 9:1996;2036-2043.
185. von Knorring L., Almay B.G.L. Neuroendocrine responses to fenfluramine in patients with idiopathic pain syndromes. Nord. Psykiatr. Tidsskr. 43:1989;61-65.
186. Walker C.D., Rivest R.D., Meaney M.J., Aubert M.L. Differential activation of the pituitary-adrenocortical axis after stress in the rat: use of two genetically selected lines (Roman low and high avoidance rats) as a model. J. Endocrinol. 123:1989;477-485.
187. Wallace D.J. The role of stress and trauma in rheumatoid arthritis and systemic lupus erythematosus. Semin. Arthritis Rheum. 16:1987;153-157.
188. Wallace D.J., Margolin K. Acute onset of fibromyalgia as a complication of IL-2 therapy. Arthritis Rheum. 31:1988;S24.
189. Wang S., Wilson J.P., Mason J.W. Stages of decompensation in combat-related post-traumatic stress disorder: a new conceptual model. Integ. Physiol. Behav. Sci. 31:1996;237-253.
190. Waylonis G.W., Heck W. Fibromyalgia syndrome. New associations. Am. J. Phys. Med. Rehab. 71:1992;343-348.
191. Weiss J.M., Sundar S.K., Becker K.J., Cierpal M.A. Behavioral and neural influences on cellular immune responses: effects of stress and interleukin-1. J. Clin. Psychiatry. 50:1989;43-53.
192. Wiegers G.J., Reul J.M.H.M., Holsboer F., de Koet E.R. Enhancement of rat splenic lymphocyte mitogenesis after short-term preexposure to corticosteroids in vitro. Endocrinology. 135:1994;1257-2351.
193. Wolff C.T., Hofer M., Mason J.W. Relationship between psychological defenses and mean urinary 17-hydroxicorticosteroid excretion rates. Methodologic and theoretical considerations. Psychosom. Med. 26:1964;592-609.
194. Yehuda R., Southwick S.M., Nussbaum G., Wahby V., Giller E.L., Mason J.W. Low urinary cortisol excretion in patients with post-traumatic stress disorder. J. Nerv. Ment. Dis. 178:1990;366-369.
195. Yehuda R., Giller E.L., Southwick S.M., Lowy M.T., Mason J.W. Hypothalamic pituitary adrenal dysfunction in posttraumatic stress disorder. Biol. Psychiatry. 30:1991;1031-1048.
196. Yehuda R., Lowy M.T., Southwick S.M., Shaffer D., Giller E.L. Increased number of glucocorticoid receptor in posttraumatic stress disorder. Am. J. Psychiatry. 148:1991;499-504.
197. Yehuda R., Boisoneau D., Mason J., Giller E.L. Glucocorticoid receptor number and cortisol excretion in mood, anxiety, and psychotic disorders. Biol. Psychiatry. 34:1993;18-25.
198. Yehuda R., Resnick H., Kahana B., Giller E.L. Long lasting hormonal alterations to extreme stress in humans: normative or maladaptive? Psychosom. Med. 55:1993;287-297.
199. Yehuda R., Southwick S.M., Krystal J.H., Bremner D., Charney D.S., Mason J.W. Enhanced suppression of cortisol following dexamethasone administration in posttraumatic stress disorder. Am. J. Psychiatry. 150:1993;83-86.
200. Yehuda R., Boisoneau D., Lowy M.T., Giller E.L. Dose-response changes in plasma cortisol and lymphocyte glucocorticoid receptors following dexamethasone administration in combat veterans with and without posttraumatic stress disorder. Arch. Gen. Psychiatry. 52:1995;538-593.
201. Yehuda R., Kahana B., Binder-Brynes K., Southwick S.M., Mason J.W., Giller E.L. Low urinary cortisol excretion in Holocaust survivors with PTSD. Am. J. Psychiatry. 152:1995;245-247.
202. Yehuda R., Kahana B., Schmeidler J., Southwick S.M., Wilson S., Giller E.L. Impact of cumulative lifetime trauma and recent stress on posttraumatic stress disorder symptoms in Holocaust survivors. Am. J. Psychiatry. 152:1995;1815-1818.
203. Yehuda R., Teicher R.L., Trestman R., Siever L.J. Cortisol regulation in posttraumatic stress disorder and major depression: a chronobiological analysis. Biol. Psychiatry. 40:1996;79-88.
204. Yehuda R. Sensitization of the hypothalamic-pituitary-adrenal axis in posttraumatic stress disorder. Ann. NY Acad. Sci. 821:1997;57-75.
205. Yehuda R., Levengood J., Schmeidler J., Wilson S., Guo L.S., Gerber D. Increased pituitary activation following metyrapone administration in PTSD. Psychoneuroendcrinology. 21:1997;1-16.
206. Yehuda R., Steiner A., Kahana B. et al. Alexithymia in Holocaust survivors with and without PTSD. J. Trauma. Stress. 10:1997;93-100.
207. Yehuda R., McFarlane A.C., Shalev A.Y. Predicting the development of posttraumatic stress disorder from acute response to a traumtic event. Biol. Psychiatry. 44:1998;1305-1313.
208. Yunus M.B. Psychological aspects of fibromyalgia syndrome: a component of the dysfunctional spectrum syndrome. Bailliere's Clin. Rheumatol. 4:1994;811-837.
209. Zaidi L.Y., Foy D.W. Childhood abuse experiences and combat related PTSD. J. Trauma. Stress. 7:1994;33-42.
210. Zeitlin S.B., McNally R.J., Cassiday K.L. Alexithymia in victims of sexual assault: an effect of repeated traumatization? Am. J. Psychiatry. 150:1993;661-663.